Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50
Closed -$13.3K 859
2024
Q2
$13.3K Hold
50
﹤0.01% 502
2024
Q1
$15.4K Buy
+50
New +$14.3K 0.01% 478
2023
Q4
Sell
-59
Closed -$15.1K 827
2023
Q3
$15.1K Sell
59
-1
-2% -$261 0.01% 438
2023
Q2
$15K Hold
60
0.01% 445
2023
Q1
$13K Buy
60
+22
+58% +$4.46K 0.01% 473
2022
Q4
$7K Sell
38
-13
-25% -$2.38K ﹤0.01% 582
2022
Q3
$9K Buy
51
+5
+11% +$1.07K ﹤0.01% 532
2022
Q2
$10K Buy
46
+3
+7% +$714 ﹤0.01% 525
2022
Q1
$11K Sell
43
-2
-4% -$474 ﹤0.01% 543
2021
Q4
$10K Buy
45
+11
+32% +$2.63K ﹤0.01% 582
2021
Q3
$9K Hold
34
﹤0.01% 604
2021
Q2
$9K Buy
+34
New +$9.41K ﹤0.01% 605

Other funds holding CPAY

Front Row Advisors's CPAY Position: Q3 2024 in Review

Front Row Advisors sold out of Corpay (CPAY) in Q3 2024, closing a stake of 50 shares — an estimated $13.3K sold.

Front Row Advisors first reported a position in CPAY in Q2 2021 and held it in 12 quarters. The position peaked at $15.4K in Q1 2024. 614 funds tracked by Wall St. Rank hold CPAY as of Q3 2024.

  • Front Row Advisors reported no remaining Corpay position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 50 Corpay shares in Q3 2024, an estimated $13.3K.
  • Front Row Advisors first reported a position in Corpay in Q2 2021 and held it in 12 quarters.
  • Front Row Advisors's Corpay position peaked at $15.4K in Q1 2024.
  • 614 funds tracked by Wall St. Rank held Corpay as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.